HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Capelli, A. Articles by Donner, C. F. Search for Related Content PubMed PubMed Citation Articles by Capelli, A. Articles by Donner, C. F.

CCR5 expression and CC chemokine levels in idiopathic pulmonary fibrosis

Division of Pulmonary Disease, "Salvatore Maugeri" Foundation, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Scientific Institute of Veruno, Veruno, Italy

CORRESPONDENCE: A. Capelli, Divisione di Pneumologia, Fondazione S. Maugeri IRCCS, Istituto Scientifico di Veruno, Veruno (Novara), Italy. Fax: 39 0322884776. E-mail: acapelli@fsm.it

Keywords: Bronchoalveolar lavage, CC chemokine, CC chemokine receptor 5, idiopathic pulmonary fibrosis

Received: July 9, 2004
Accepted December 26, 2004

CC chemokines play an important role in the pathogenetic mechanisms of interstitial lung disease, while a downregulation of CC chemokine receptor (CCR)5 in the fibrotic stages of sarcoidosis has been observed.

To evaluate the involvement of CC chemokines and the expression of CCR5 in idiopathic pulmonary fibrosis (IPF) and, more specifically, in usual interstitial pneumonia, 35 subjects were studied. CC chemokine ligand (CCL)2, CCL3 and CCL4 levels were measured in the bronchoalveolar lavage fluid (BALF) of 18 nonsmoker control subjects and 17 patients affected by IPF. CCR5 expression was evaluated in alveolar macrophages and lymphocytes.

The BALF levels of all chemokines were significantly increased in IPF: median (range) CCL3 1.6 (1.0–11.1) versus 1.2 (0.0–3.8) pg·mL^–1; CCL4 6.2 (1.3–96.0) versus 3.4 (0.3–6.8) pg·mL^–1; and CCL2 60.1 (16.7–251.3) versus 4.6 (0.5–119.4) pg·mL^–1. CCL2 levels correlated negatively with the carbon monoxide diffusing capacity of the lung (D_L,CO) and arterial oxygen tension. CCR5 expression was significantly reduced in lymphocytes from IPF compared with controls.

The CC chemokines investigated are involved in the inflammatory mechanisms of idiopathic pulmonary fibrosis, and the results are in agreement with the hypothesis of a downregulation of the T-helper 1 immunological response in this disease.

This article has been cited by other articles:

				G. Trujillo, E. C. O'Connor, S. L. Kunkel, and C. M. Hogaboam A Novel Mechanism for CCR4 in the Regulation of Macrophage Activation in Bleomycin-Induced Pulmonary Fibrosis Am. J. Pathol., May 1, 2008; 172(5): 1209 - 1221. [Abstract] [Full Text] [PDF]

				C. P. Baran, J. M. Opalek, S. McMaken, C. A. Newland, J. M. O'Brien Jr., M. G. Hunter, B. D. Bringardner, M. M. Monick, D. R. Brigstock, P. C. Stromberg, et al. Important Roles for Macrophage Colony-stimulating Factor, CC Chemokine Ligand 2, and Mononuclear Phagocytes in the Pathogenesis of Pulmonary Fibrosis Am. J. Respir. Crit. Care Med., July 1, 2007; 176(1): 78 - 89. [Abstract] [Full Text] [PDF]